Venus Concept Inc. (VERO) — SEC Filings
Venus Concept Inc. (VERO) — 50 SEC filings. Latest: 8-K (Dec 2, 2025). Includes 34 8-K, 4 10-Q, 3 SC 13D/A.
View Venus Concept Inc. on SEC EDGAR
Overview
Venus Concept Inc. (VERO) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Dec 2, 2025: Venus Concept Inc. entered into a material definitive agreement on November 25, 2025. The filing also includes financial statements and exhibits related to this agreement. The company, formerly known as Restoration Robotics, Inc., is incorporated in Delaware and headquartered in Toronto, Ontario.
Sentiment Summary
Across 50 filings, the sentiment breakdown is: 3 bearish, 47 neutral. The dominant filing sentiment for Venus Concept Inc. is neutral.
Filing Type Overview
Venus Concept Inc. (VERO) has filed 34 8-K, 4 10-Q, 2 8-K/A, 1 S-1/A, 1 S-1, 1 DEFA14A, 2 DEF 14A, 1 10-K, 3 SC 13D/A, 1 SC 13G/A with the SEC between Sep 2024 to Dec 2025.
Filings by Year
Recent SEC Filings (50)
Risk Profile
Risk Assessment: Of VERO's 49 recent filings, 3 were flagged as high-risk, 32 as medium-risk, and 14 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $13,776,000 |
| Net Income | -$22,549,000 |
| EPS | N/A |
| Debt-to-Equity | 21.7 |
| Cash Position | $4,312,000 |
| Operating Margin | N/A |
| Total Assets | $61,624,000 |
| Total Debt | $30,068,000 |
Key Executives
- Michael Mandarello
- Richard Raymer
- Dr. Mark Foley
- Ms. Brenda L. Freeman
- Dr. Mark T. Smith
- Ms. Jennifer L. Smith
Industry Context
Venus Concept operates in the aesthetic medical device industry, facing competition from established players and emerging technologies. The industry is characterized by innovation, regulatory oversight, and a focus on patient outcomes and physician adoption. Trends include the demand for minimally invasive procedures and advancements in energy-based technologies.
Top Tags
material-agreement (23) · corporate-action (11) · equity-sale (6) · financial-reporting (6) · financials (5) · filing (5) · sec-filing (4) · material-definitive-agreement (4) · SEC Filing (3) · financial-statements (3)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Net Loss (Q3 2025) | $22.549M | Increased from $9.302M in Q3 2024, indicating worsening financial performance. |
| Net Loss (YTD Sept 2025) | $46.657M | Widened from $38.955M in YTD Sept 2024, highlighting persistent unprofitability. |
| Accumulated Deficit | $355.548M | Increased from $308.899M at Dec 31, 2024, raising substantial doubt about going concern. |
| Loss on Debt Extinguishment (YTD Sept 2025) | $14.211M | Significant expense contributing to net loss, up from $11.355M in YTD Sept 2024. |
| Total Revenue (Q3 2025) | $13.776M | Decreased from $15.007M in Q3 2024, showing a decline in sales. |
| Venus Hair Business Sale Valuation | $20M | Potential cash injection, but currently subject to a legal dispute. |
| Total Operating Expenses (Q3 2025) | $18.313M | Increased from $17.078M in Q3 2024, contributing to operational losses. |
| Net Cash Used in Operating Activities (YTD Sept 2025) | $16.648M | Increased from $7.259M in YTD Sept 2024, indicating higher cash burn. |
| SEC File Number | 001-38238 | Identifies the company's filings with the SEC. |
| IRS Employer Identification Number | 06-1681204 | Company's tax identification number. |
| EIN | 06-1681204 | Employer Identification Number for Venus Concept Inc. |
| Total Revenue | $29.335M | Decreased from $34.061M in 2024 for the six months ended June 30, 2025, a 13.87% decline. |
| Net Loss | $24.108M | For the six months ended June 30, 2025, an improvement from $29.653M in 2024. |
| Net Cash Used in Operating Activities | $11.758M | For the six months ended June 30, 2025, significantly higher than $4.210M in 2024. |
| Venus Hair Business Sale Price | $20M | All-cash transaction with Meta Healthcare Group, subject to working capital adjustment. |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Venus Concept Inc. (VERO)?
Venus Concept Inc. has 50 recent SEC filings from Sep 2024 to Dec 2025, including 34 8-K, 4 10-Q, 3 SC 13D/A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of VERO filings?
Across 50 filings, the sentiment breakdown is: 3 bearish, 47 neutral. The dominant sentiment is neutral.
Where can I find Venus Concept Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Venus Concept Inc. (VERO) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Venus Concept Inc.?
Key financial highlights from Venus Concept Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for VERO?
The investment thesis for VERO includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Venus Concept Inc.?
Key executives identified across Venus Concept Inc.'s filings include Michael Mandarello, Richard Raymer, Dr. Mark Foley, Ms. Brenda L. Freeman, Dr. Mark T. Smith and 1 others.
What are the main risk factors for Venus Concept Inc. stock?
Of VERO's 49 assessed filings, 3 were flagged high-risk, 32 medium-risk, and 14 low-risk.
What are recent predictions and forward guidance from Venus Concept Inc.?
Forward guidance and predictions for Venus Concept Inc. are extracted from SEC filings as they are enriched.